Jin-Qiu (Jessie) Chen, Ph.D.
Dr. Jin-Qiu (Jessie) Chen has 25+ years of advanced experience in therapeutic research, translational medicine, biomarker study and diagnostics development. She is currently the vice president in product and application development of ACRO Biosystems. At this position, Dr. Chen develops strategies, builds resources and strategic partnerships, establishes competitive R&D forces…...
Charles Hu, Ph.D.
A translational biomedical engineer with a strong background in business development and investments, Charles’s vision is in bringing about a vibrant healthcare innovation and investment ecosystem in the HK Greater Bay Area. He obtained his PhD from Johns Hopkins University, BS from University of California, Berkeley, and his scientific expertise…...
Simon Je, M.B.A.
An experienced entrepreneur with extensive knowledge in Global Financial & Wealth Management industry, Mr. Je has established the SFC licensed Investment Bank & International Wealth Management Company for global family offices, Institutional investors & retail clients. He has ample knowledge on digital asset management and created the latest FinTech &…...
Eifion Phillips, Ph.D., J.D.
A medicinal chemistry scientist turned patent attorney, Dr. Eifion Phillips has helped secure his clients’ intellectual property portfolios across various fields and innovations, including those pertaining to small and large molecule pharmaceuticals, drug formulation and delivery, methods of treatment, biochemical processes and manufacturing. He previously worked at Omeros Corporation, serving…...
Rose Wang, M.B.A.
Rose Wang is a mission-driven entrepreneurial leader. She is the Founder & CEO of 1104Health, a digital health company working at the intersection of technology, healthcare and life sciences industries, leveraging AI and automation to bring cancer patients equitable access to precision oncology innovations globally. Ms. Wang is a serial…...
Yung-Chi Cheng, Ph.D.
Dr. Yung-Chi Cheng received his B.S. in chemistry from Tunghai University in Taiwan and his Ph.D. in biochemical pharmacology from Brown University. He then performed his postdoctoral work at Yale University from 1972 to 1974. Upon completing this work, Dr. Cheng joined the faculty of the Roswell Park Memorial Institute…...
Pamela D. Garzone, Ph.D.
Pamela D. Garzone is a respected pharmaceutical executive with a significant record of achievement in drug development and leadership, ascending to the level of Chief Medical Officer. She has led teams successfully through the regulatory process, culminating in the clearance of multiple INDs in different therapeutic areas and approval of…...